Found: 22
Select item for more details and to access through your institution.
Quantification of Radiation Injury on Neutropenia and the Link between Absolute Neutrophil Count Time Course and Overall Survival in Nonhuman Primates Treated with G-CSF.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 6, p. 1, doi. 10.1007/s11095-020-02839-3
- By:
- Publication type:
- Article
Mathematical Disease Progression Modeling in Type 2/3 Spinal Muscular Atrophy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 5, p. 508, doi. 10.1016/j.clpt.2005.07.010
- By:
- Publication type:
- Article
Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approach.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 5, p. 2128, doi. 10.1111/bcp.15133
- By:
- Publication type:
- Article
Pharmacokinetic–pharmacodynamic modelling of neutrophil response to G‐CSF in healthy subjects and patients with chemotherapy‐induced neutropenia.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 911, doi. 10.1111/bcp.13504
- By:
- Publication type:
- Article
Population pharmacokinetic/ pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, p. 86, doi. 10.1111/j.1365-2125.2008.03140.x
- By:
- Publication type:
- Article
A receptor theory-based semimechanistic PD model for the CCR5 noncompetitive antagonist maraviroc.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, p. 95, doi. 10.1111/j.1365-2125.2008.03141.x
- By:
- Publication type:
- Article
Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID‐19 vaccine Ad26.COV2.S in humans.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 10, p. 1485, doi. 10.1002/psp4.13025
- By:
- Publication type:
- Article
A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 58, n. 6, p. 618, doi. 10.1111/j.1365-2125.2004.02224.x
- By:
- Publication type:
- Article
Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and Adolescents with Epilepsy: Dosing Recommendations.
- Published in:
- Clinical Pharmacokinetics, 2008, v. 47, n. 5, p. 333, doi. 10.2165/00003088-200847050-00004
- By:
- Publication type:
- Article
Population pharmacokinetics of levetiracetam in Japanese and Western adults.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
- Published in:
- 2007
- By:
- Publication type:
- journal article
A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2015, v. 42, n. 4, p. 315, doi. 10.1007/s10928-015-9423-3
- By:
- Publication type:
- Article
Using early biomarker data to predict long-term bone mineral density: application of semi-mechanistic bone cycle model on denosumab data.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2015, v. 42, n. 4, p. 333, doi. 10.1007/s10928-015-9422-4
- By:
- Publication type:
- Article
The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2011, v. 38, n. 1, p. 41, doi. 10.1007/s10928-010-9175-z
- By:
- Publication type:
- Article
An example of optimal phase II design for exposure response modelling.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2010, v. 37, n. 5, p. 475, doi. 10.1007/s10928-010-9168-y
- By:
- Publication type:
- Article
Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2010, v. 37, n. 2, p. 157, doi. 10.1007/s10928-010-9151-7
- By:
- Publication type:
- Article
Clustering and Kernel Density Estimation for Assessment of Measurable Residual Disease by Flow Cytometry.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 5, p. 317, doi. 10.3390/diagnostics10050317
- By:
- Publication type:
- Article
Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 4, p. 807, doi. 10.1111/cts.12777
- By:
- Publication type:
- Article
Comparison of Sublingual and Oral Prazepam in Normal Subjects.
- Published in:
- Neuropsychobiology, 1988, v. 19, n. 4, p. 186, doi. 10.1159/000118458
- By:
- Publication type:
- Article
Comparison of Sublingual and Oral Prazepam in Normal Subjects.
- Published in:
- Neuropsychobiology, 1987, v. 18, n. 2, p. 77, doi. 10.1159/000118397
- By:
- Publication type:
- Article